IGC Pharma Launches PRISM Application Layer for Alzheimer’s AI
IGC Pharma said PRISM will move its MINT-AD Alzheimer’s AI from prediction toward actionable workflows. B2B, B2B2C and online commercialization are under evaluation.
IGC Pharma said PRISM will move its MINT-AD Alzheimer’s AI from prediction toward actionable workflows. B2B, B2B2C and online commercialization are under evaluation.